Changes in adrenal renin,
It is well established that prolonged ACTH treatment, which initially increases aldosterone secretion, causes the plasma aldosterone concentration to fall to basal values or below (1, 8, 13, 17) . Such an effect of ACTH has been observed in both human subjects and animals. In patients with Cushing disease due to excess ACTH production, aldosterone secretion is normal or low. Several studies have demostrated a suppressed renin-angiotensin system following a few days treatment with ACTH, leading to the suggestion that the impeded function of the renin-angiotensin system resulting from sodium retention during prolonged ACTH treatment might mediate the decline in aldosterone secretion (2, 20) . Other investigators have reported low plasma aldosterone values after long-term treatment with ACTH in spite of a sustained high level of PRA (17, 19) .
Reduction of the amount of several biosynthetic enzymes in the adrenal glomerulosa zone by prolonged ACTH treatment has been reported (1). The 11-hydroxylase ac- tivity and 18-hydroxylase activity were decreased, suggesting that prolonged ACTH treatment affects the late pathway in the inhibition of aldosterone biosynthesis.
It has been widely accepted that a reninlike enzyme in the adrenal gland participates in the regulation of aldosterone secretion (3, 5, 15, 16) . Additional studies have revealed the existence of adrenal angiotensin I, II, III and an angiotenin converting enzyme (6, 11, 14) , indicating the possibillity of full components of the renin-angiotensin system being present in the adrenal gland. The present experiments were undertaken to determine the changes in adrenal renin in the inhibitory action of prolonged ACTH treatment on aldosterone. 
Discussion
The present experiments confirm the results of previous studies in which prolonged ACTH treatment returned the PA to basal levels or below while short-term ACTH treatment stimulated aldosterone release (1, 8, 13, 17) . Several mechanisms have been proposed to explain such biphasic aldosterone responses to prolonged ACTH stimulation, involving an initial elevation followed by diminished release. Reduction of PRA resulting from sodium retention caused by prolonged treatment with ACTH was considered to suppress aldosterone release (2, 20) .
However, the present data which demonstrate similar changes in PRA, i.e. slight but not significant decreases, following both short-and long-term ACTH stimulation, which induced opposing changes in PA or adrenal renin, do not indicate such a mechanism.
Attempts have been made to explain the chronic effect of ACTH on aldosterone based on changes in metabolic clearance rate (12, 22) . However, the marked reduction of the adrenal aldosterone concentration in the present study suggests primary suppression of aldosterone production in the adrenal gland.
The effect of prolonged ACTH treatment on aldosterone release seems therefore to be attributable to the inhibition of aldosterone biosynthesis. Several reports have demonstrated no response of aldosterone after prolonged ACTH treatment to exogenous angiotensin II (1, 7) . Morphological changes in the glomerulosa zone were observed, and were considered to be a cause of the attenuation of aldosterone release (10, 18) . Morphological changes in the glomerulosa zone could lead to a poor response of aldosterone release to angiotensin II or ACTH. However, a high response of adrenal renin still remained after prolonged ACTH treatment.
Since the presence of a renin-like enzyme was identified in the adrenal gland (21), many studies on this enzyme have been undertaken.
The parallel changes in adrenal renin and adrenal aldosterone observed after short-term ACTH treatment are consistent with previous reports which support the importance of adrenal renin in the regulation of aldosterone release.
In contrast, prolonged ACTH treatment caused reciprocal changes in the adrenal renin and aldosterone concentration. Ganten et al. (5) described a significant reduction of PA in the absence of change in adrenal renin in rats bearing a transplanted ectopic anterior pituitary tumor for 52 days. Although they suggested a close relation between adrenal renin and aldosterone release, their results question the role of adrenal renin in the control of aldosterone release.
Our data seem to emphasize their
While the site of action of the adrenal renin-angiotensin system remains unclear, it is possible that prolonged ACTH treatment could exert its influence after the site where the adrenal renin-angiotensin system acts in the aldosterone biosynthetic pathway. Aguilera et al. (1) reported decreases in angiotensin II receptors in adrenal glomerulosa cells during prolonged ACTH treatment.
If adrenal renin reflects adrenal angiotensin II, it can be supposed that receptors of angiotensin II in the adrenal glomerulosa cells were also decreased by prolonged ACTH treatment.
A diminished action of adrenal angiotensin II might stimulate adrenal renin release as well as an interaction between renal renin and circulating angiotensin II. Another possibility is that even if both adrenal renin and angiotensin II are increased after prolonged ACTH treatment, these substanses cannot finally stimulate aldosterone biosynthesis. The response of aldosterone secretion to ACTH in adrenal glomerulosa cells from rats treated by prolonged ACTH administration was reduced in the absence of a fall in the cyclic AMP response to the peptide (1).
The unaffected response of cyclic AMP to ACTH in such glomerulosa cells from rats treated by prolonged ACTH administration could explain the high levels of adrenal renin after prolonged ACTH treatment in the present experiments, implicating cyclic AMP as an apparently important mediator for renin release in the kidney.
The lack of parallel changes in adrenal renin and aldosterone following prolonged ACTH treatment would support a complex role for adrenal renin in the regulation of aldosterone release.
Although prolonged ACTH treatment stimulates adrenal renin, probably as a consequence of increased cyclic AMP, the treatment did not affect any other pathway.
Aguilera et al.
(1) reported suppressed 11-hydroxylase and 18-hydroxylase activities in adrenal glomerulosa cells from rats treated by prolonged ACTH administration.
Oelkers (19) also demonstrated decreased aldosterone accompanied by reduced 18-OH-corticosterone. These results prove that prolonged ACTH treatment caused lesions of the late enzyme activities in the adrenal zona glomerulosa. The adrenal renin or renin-angiotensin system may thus act at an early step in the aldosterone biosynthesis pathway. Also prolonged ACTH treatment might suppress the stimulatory action of the adrenal reninangiotensin system on aldosterone release. However, it is necessary to elucidate details of changes in adrenal angiotensin II in further studies.
